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ABSTRACT  
   
Long term high fat diets (HFD) are correlated with the development of diabetes 
and kidney disease. However, the impact of short term high fat intake on the etiology of 
kidney disease has not been well-studied. Therefore, this study examined the impact of a 
six week HFD (60% fat) on kidney structure and function in young male Sprague-
Dawley rats. Previous studies have shown that these animals develop indices of diabetes 
compared to rats fed a standard rodent chow (5% fat) for six weeks. The hypothesis of 
this study is that six weeks of HFD will lead to early stages of kidney disease as 
evidenced by morphological and functional changes in the kidney. Alterations in 
morphology were determined by measuring structural changes in the kidneys (changes in 
mass, fatty acid infiltration, and structural damage). Alterations in kidney function were 
measured by analyzing urinary biomarkers of oxidative RNA/DNA damage, renal tissue 
lipid peroxidation, urinary markers of impaired kidney function (urinary protein, 
creatinine, and hydrogen peroxide (H2O2)), markers of inflammation (tumor necrosis 
factor alpha (TNFα) and interleukin 6 (IL-6)), as well as cystatin C, a plasma biomarker 
of kidney function. The results of these studies determined that short term HFD intake is 
not sufficient to induce early stage kidney disease. Beyond increases in renal mass, there 
were no significant differences between the markers of renal structure and function in the 
HFD and standard rodent chow-fed rats.  
ii 
ACKNOWLEDGMENTS 
 I would like to thank my committee members Dr. Johnston and Dr. Mayol-Kreiser 
for their support and feedback throughout my thesis project. I would like to express the 
deepest gratitude to my mentor Dr. Sweazea for her support, encouragement, and 
impressive ability to be answer every question I had. I have grown as a person and as a 
researcher thanks to her guidance; I could not have asked for a better mentor.  
 This thesis was accomplished with supporting funds from the Graduate Research 
Support Program and from Sigma Xi of Arizona State University.  
 Finally, I would like to thank Derek Juengel, my family, the students in Dr. 
Sweazea’s laboratory, and my friends. I could not have completed this thesis without 
their unwavering love and patience and will be eternally grateful.  
 
 
iii 
TABLE OF CONTENTS  
          Page 
LIST OF TABLES ..................................................................................................................vi  
LIST OF FIGURES............................................................................................................... vii  
CHAPTER 
1     INTRODUCTION ....................................................................................................... 1  
Overview....................................................................................................1  
Purpose of the Study..................................................................................2  
Research Aim and Hypothesis ..................................................................2  
Definition of Terms ...................................................................................3  
Delimitations..............................................................................................5  
Limitations.................................................................................................5  
2     REVIEW OF LITERATURE .................................................................................... 6  
Introduction: Pre-diabetes, Obesity and Renal Disease............................6  
Visceral Adiposity ...................................................................................12  
Obesity and High Fat Diets (HFD) on Renal Function ..........................15  
Markers of Morphological Changes from Renal Disease ......................17  
Renin-Angriotenin-Aldonsteron System (RAAS) Activation................19  
Oxidative Stress and Renal Disease........................................................20  
Cystatin C ................................................................................................23  
Hydrogen Peroxide..................................................................................24  
Biomarkers of Inflammation: TNFα and IL-6........................................25  
Rats as a Model of Metabolic Syndrome................................................31  
iv 
CHAPTER              Page 
Conclusion ...............................................................................................33  
3     MATERIALS AND METHODS ............................................................................ 36  
Animal Models ........................................................................................36  
Study Design............................................................................................36  
Laboratory Analysis ................................................................................39 
Variables ..................................................................................................44  
Statistical Analysis ..................................................................................46  
4     RESULTS .................................................................................................................  47  
Structural Changes...................................................................................47 
Biomarkers of Function...........................................................................48 
Inflammatory Markers.............................................................................48  
Oxidative Stress Markers ........................................................................49 
Cumulative Information ..........................................................................49  
5     DISCUSSION ..........................................................................................................  66 
REFERENCES.......................................................................................................................72 
APPENDIX 
A      HIGH FAT DIET COMPONENTS – D12492 ...................................................... 80  
B      STANDARD RODENT CHOW DIET COMPONENTS .................................... 84  
C      HEMATOXYLIN AND EOSIN STAIN PROTOCOL ........................................ 86  
D      OIL RED O STAIN PROTOCOL.......................................................................... 88  
E      CREATININE PROTOCOL .................................................................................. 90  
F      CYSTATIN C PROTOCOL .................................................................................. 95  
v 
Page 
G      HYDROGEN PEROXIDE PROTOCOL ............................................................ 101  
H     IL-6 ANTIBODY................................................................................................... 107  
I      TNFα ANTIBODY ............................................................................................... 110  
J      BETA-ACTIN ANTIBODY ................................................................................. 113  
K     TNFα ELISA PROTOCOL................................................................................... 117  
L      TBARS PROTOCOL ........................................................................................... 124  
M     OXIDATIVE DNA/RNA PROTOCOL............................................................... 127  
vi 
LIST OF TABLES 
Table Page 
1. Summary of Animal Subsets…………………………………………………….. 38 
2. Summary of Descriptive Statistics……………..………………………………... 65 
vii 
LIST OF FIGURES 
Figure Page 
1.     Nephron Structure ........................................................................................... 8 
2.      Truncal Obesity, Insulin Resistance, and CKD ............................................ 12 
3.      Overview of Major Adipokines and Their Role in CKD ............................. 14 
      4.      Inflammatory Pathways That Induce Oxidative Stress in Obesity ..............  21 
5.      Muscular IL-6 Secretion and Effects on Metabolism ................................... 28 
6.      Biological Role of Contraction Induced IL-6 ............................................... 29 
7.      Body Mass of Chow and HFD Rats .............................................................. 50 
8.      Epididymal Fat Pad Mass of Chow and HFD-Fed Rats ............................... 51 
9.      Waist Circumference of Chow and HFD Rats ............................................. 52 
10.    Tail Lengths of Chow and HFD Animals ..................................................... 53 
11.    Renal Mass of Chow and HFD Rats ............................................................. 54 
      12.    Hematoxylin and Eosin Staining of Kidneys for Morphology ..................... 55 
13.    Oil Red O Staining of Kidneys ..................................................................... 56 
     14.    Urine Protein:Creatinine Ratios of Chow-Fed and HFD-Fed Rats ..............  57 
15.    Urine Creatinine in Chow-Fed and HFD-Fed Rats ....................................... 58 
16.    Plasma Cystatin C in Chow and HFD Rats .................................................. 59 
      17.    Urinary Hydrogen Peroxide:Creatinine Ratio in Chow and HFD Rats ......  60 
             18.    Renal Tissue TNFα Protein Expression in Chow and HFD Rats ................. 61 
      19.    Renal Tissue IL-6 Protein Expression in Chow and HFD Rats ..................  62 
20.  Renal Tissue TBARS in Chow and HFD rats ..........................................  63 
 
21.    Oxidative DNA Damage in the Plasma of Chow and HFD-Fed rats ........... 64
1 
CHAPTER 1 
INTRODUCTION 
Overview 
 According to the 2011 National Diabetes Fact Sheet, 25.8 million children and 
adults living in the United States are diabetic. Major complications of diabetes include 
cardiovascular disease and kidney disease [1]. The 2014 National Chronic Kidney 
Disease (CKD) Fact Sheet states that more than 33% of adults who have diabetes also 
have CKD, making diabetes the leading cause of renal failure in the United States [1,2]. 
However, the impact of poor nutrition on the development of kidney disease has been not 
been well-studied, despite the major contribution of poor dietary habits to the 
development of diabetes. According to a paper by Deji et al. (2009), the mechanisms 
leading to the development of CKD in subjects with metabolic syndrome are not well-
understood [3]. Deji et al. (2009) fed 1.5 month old mice a high fat diet (HFD) (60% fat) 
for 12 weeks. The mice were found to develop hypertension and elevated plasma insulin 
and glucose concentrations. Moreover, the animals showed evidence of kidney disease as 
they had increased proteinuria, changes in kidney morphology, and renal steatosis as 
evidenced by microscopy [3]. Similarly, Altunkaynak et al. (2008) demonstrated that 
feeding adult female Sprague-Dawley rats a moderate fat diet (30% fat) for 12 weeks 
caused the animals to become overweight and to develop increased kidney mass with 
significant morphological changes indicative of renal disease [4]. Additionally, others 
have shown that feeding spontaneously hypertensive rats a high fat diet (58% fat) results 
in hypertension, lipid infiltration and increased markers of inflammation in the kidneys 
[5].  
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 Studies of the effects of shorter term feeding protocols to mimic early onset 
pathological changes with high fat feeding are not evident in the literature. For this 
reason, the effects of feeding rats a HFD (60% fat) for six weeks will be studied to 
determine the effects of a shorter term feeding protocol on the morphology of the kidney 
and renal biomarkers of function. Prior studies by the Sweazea laboratory have shown 
that young (1.5 month old) male Sprague-Dawley rats fed a HFD (60% kcal from fat) for 
six weeks develop indices of diabetes and cardiovascular disease: increased body fat, 
high blood glucose concentrations, impaired glucose tolerance and hypertension [6,7]. 
Unpublished observations from the Sweazea laboratory also demonstrate that these 
animals develop hepatic steatosis. However, these prior studies did not examine kidney 
morphology or function. Examining the effect of the short term HFD on the kidney fills a 
gap in the literature and allows for a better understanding of the early pathological 
changes that occur from consuming a HFD even for a short period. 
 
Purpose of Study 
 The purpose of the study was to examine the effects of a short term (six week) 
HFD (60% fat) on kidney morphology and function in male Sprague-Dawley rats. The 
HFD-fed rats were compared with rats fed a standard rodent chow diet containing 5% fat.  
 
Research Aim and Hypothesis 
Research Aim 
The aim of this study was to examine the implications of a HFD consumed over a 
short period of time on kidney structure and function in rats.  
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Hypothesis 
Six weeks of HFD (60% fat) will lead to early stages of renal disease in 1.5 month 
old Sprague-Dawley rats, as evidenced by morphological and functional changes in the 
kidney, compared to control group of rats on 5% fat diet. 
 
Definition of Terms 
8-hydroxy-2'-deoxyguanosine (8-OHdG): Biomarker of oxidative damage. 
Advanced glycation end products: End productions produced by glycation reactions that 
are implicated in multiple disease states. 
Chronic kidney disease (CKD): Gradual loss of renal function over time, during which 
the kidneys lose the ability to adequately filter blood and remove waste products. 
Cystatin C: Biomarker of renal function. 
Diabetic kidney disease (DKD): Kidney disease caused by uncontrolled diabetes. 
Glomular filtration rate (GFR): Estimation of the per minute filtration rate of glomeruli. 
Glomerulosclerosis: The scaring or hardening of the glomeruli. 
Glomerulomegaly: Abnormal glomerular enlargement. 
High fat diet (HFD): Rodent diet consisting of 20% kcal from protein, 20% kcal from 
carbohydrates, and 60% kcal from fat (Appendix A). 
Hydrogen Peroxide (H2O2): Biomarker of inflammation, oxidative stress, and early renal 
dysfunction. 
Hyperglycemia: High blood glucose levels. 
Interleukin 6 (IL-6): Biomarker of inflammation; pro-inflammatory cytokine. 
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Metabolic syndrome: A clustering of risk factors such as hypertension, hyperglycemia, 
high cholesterol and abdominal fat that increase the risk of developing cardiovascular 
disease.   
Oxidative stress: An imbalance between antioxidant defenses and radical oxygen species. 
Proteinuria: Urinary protein excretion, an indication of renal dysfunction. 
Renin-angiotensin-aldosterone system (RAAS): Hormonal system that regulates fluid and 
blood pressure balance.  
Reactive Oxygen Species (ROS): Oxygen molecules containing an unpaired electron that 
are able to oxidize nucleic acids, lipids and proteins, causing a chain reaction of damage 
to tissues and oxidative stress.  
Renal failure: Medical condition in which the kidneys are not able to adequately filter 
blood and remove waste products; can be chronic or acute in nature.  
Short term diet: Six weeks of feeding. 
Standard rodent chow: Rodent chow consisting of: 18.9% kcal from protein, 57.33% kcal 
from carbohydrates, and 5% fat (Appendix B). 
Tubular reabsorption: The flow of glomerular fluid from the proximal convoluted tubule 
into the peritubular capillaries, which allows for specific substrates to be reabsorbed into 
the blood. 
Tubular secretion: Transfer of substrates from the blood into the glomerular fluid for 
excretion.   
Tumor necrosis factor alpha (TNFα): Biomarker of inflammation; pro-inflammatory 
cytokine. 
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Delimitations 
The rats used in the study are male 1.5 month old Sprague-Dawley rats. The 
effects of a diet consisting of 60% fat for six weeks on renal morphology and structure 
were examined.  
 
Limitations 
Limitations include the assumption that metabolic syndrome caused by HFD 
damaged renal function to the point of significant structural damage and altered 
functional biomarkers. The samples that were used for this study (plasma, urine and 
kidneys) were collected in prior studies and stored at -80°C for up to three years prior to 
analysis.  
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CHAPTER 2 
REVIEW OF LITERATURE 
Introduction: Pre-Diabetes, Obesity and Renal Disease 
 According to the 2011 National Diabetes Fact Sheet, 25.8 million children and 
adults living in the United States are diabetic; major complications of which include 
cardiovascular disease and kidney disease [1]. Furthermore, the 2014 National Chronic 
Kidney Disease (CKD) Fact Sheet states that one in three adults over the age of 20 who 
have diabetes also have CKD, making diabetes the leading cause of renal failure in the 
United States [1,2]. The average annual growth of incidences of diabetes worldwide is 
nearly double the growth of the global population [8]. Research has shown a clear 
connection between poorly controlled diabetes and renal dysfunction.  
Fully functioning kidneys filter 150 quarts of blood and produce two quarts of 
urine daily. The basic filtering unit of the kidney is the nephron and roughly one million 
are contained in a human kidney. Each nephron filters a small amount of blood and 
consists of a renal corpuscle and renal tubule. The renal corpuscle is made up of the 
Bowman’s capsule, which is an epithelial cup that surrounds the glomerulus. The 
glomerulus contains capillaries that join the afferent arteriole (which brings blood into the 
glomerulus) and the efferent arteriole (which removes blood from the glomerulus). The 
smaller diameter of the efferent arteriole in comparison to the afferent arteriole increases 
the blood pressure within the glomerulus. The Bowman’s capsule has two walls; the inner 
wall adheres to the outer wall of the glomerulus and forms a filtration membrane. The 
increased blood pressure created by the differing diameters of the two arterioles 
facilitates the passage of excess fluid and solutes from the glomerulus into the Bowman’s 
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capsule. This process along with the presence of specialized cells prevents erythrocytes, 
proteins, and other large molecules from entering the urine. Glomular filtration rate 
(GFR) is an estimation of the per minute filtration speed of the glomeruli and is 
considered the gold standard marker of kidney function [9].  
The glomerular filtrate then travels from the Bowman’s capsule to the proximal 
convoluted tubule where tubular reabsorption and tubular secretion occur. At this point, 
water and solutes (i.e. sodium, chloride, bicarbonate, potassium, glucose, calcium, etc) 
are removed from the filtrate and reabsorbed by the blood while other solutes, such as 
uric acid, are secreted into the tubular fluid. The fluid then continues into the Loop of 
Henle, through which it enters the renal medulla and subsequently returns to the renal 
cortex. As the glomerular fluid enters the distal convoluted tubule, additional sodium, 
calcium, bicarbonate, hydrogen, chloride and water are reabsorbed into the blood while 
potassium, urea, hydrogen ions and wastes are secreted into the tubular fluid. Finally, any 
excess water still in the tubular fluid is reabsorbed into the blood and the final tubular 
product, urine, is excreted via the bladder [10]. Urine creatinine clearance is a useful 
marker of the glomerular filtration rate as it is negligibly reabsorbed or secreted after 
filtration. Figure 1 illustrates the structure of the nephron.  
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Increased plasma glucose concentrations (i.e. hyperglycemia), a risk factor of 
both CKD and cardiovascular disease, have been shown to damage the filtering ability of 
the kidneys. Hyperglycemia may initiate hypertrophy and proliferation of the mesangial 
cells, which are responsible for maintaining the structure of glomerular capillaries and 
modulating glomerular filtration. Additionally, hyperglycemia is positively associated 
with glomerular basement membrane thickening and increases in mesangial matrix 
production and mesangial cell apoptosis [11,12]. Three mechanisms believed to explain 
the harmful effects of hyperglycemia on glomerular filtration are: the production of 
advanced glycation end products via the glycosylation of free amino acids; the activation 
of protein kinase C, which instigates the secretion of vasodilatory prostanoids and 
Figure 1 – Nephron structure. 
Blood is initially filtered through the glomerulus. Excess fluids and solutes pass through 
the Bowman’s capsule and into the proximal convoluted tubule (PCT) where the majority 
of reabsorption occurs. From there the filtrate enters the loop of Henle and then the distal 
convoluted tubule (DCT) where the majority of secretion occurs. The urine then enters the 
collecting duct where urine is either concentrated to conserve water or diluted to rid the 
body of excess water. The urine then collects in the bladder and can be excreted from the 
body through the ureters and urethra.  
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glomerular hyperfiltration; and the acceleration of the aldose reductase pathway [13-15]. 
The stressing of glomerular filtration eventually contributes to the leakage of proteins 
such as albumin, which are then excreted in the urine. The presence of albumin in the 
urine is called albuminuria and proteinuria is defined as an excess of proteins found in 
urine. Therefore, albuminuria and proteinuria are common markers used to assess renal 
function [8,16,17]. Fully functioning kidneys excrete little to no protein and the presence 
of urinary protein indicates a decline in renal filtering abilities and the pathogenesis of 
CKD.  
Microalbuminuria and macroalbuminuria are used as assessment tools in the 
diagnosis of renal dysfunction. Emerging research has shown the humans can progress to 
end-stage renal disease without exhibiting signs of microalbumineria or 
macroalbumineria [8]. Albumin is a protein; however the specificity of testing for only 
one protein can be limiting. Testing for the excretion of total proteins in the urine, 
proteinuria, is therefore also a common practice and a useful marker of renal function 
[5,16,17]. Multiple studies have found a stronger association between proteinuria and 
renal disease outcomes than any other tested factors [17]. Proteinuria is used not only as a 
marker of kidney damage, but also as a risk factor for disease progression, a hypothesized 
marker of endothelial dysfunction, and a surrogate outcome for the progression of kidney 
disease [17]. In fact, clinical studies on humans have identified proteinuria as the first 
clinical symptom of kidney damage that can appear years before the GFR declines [18]. 
Cellular damage caused injury, pathogens, or allergies promotes a bodily defense known 
as inflammation. Inflammation may be the initial indication of renal damage; however, it 
cannot be examined in human kidneys in vivo, whereas it may be readily examined in 
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animal models. Chronic inflammation is a prolonged, maladapted response that 
pathologically consists of both the repair and destruction of tissues [19]. 
Kidney failure is the final stage of CKD. In humans, CKD is diagnosed in 
individuals who demonstrate renal damage through albuminuria or decreased renal 
function (GFR of less than 60 mL/min) for at least three months. Renal failure is 
categorized as a GFR of less than 15 mL/min. As the incidence of diabetes continues to 
increase throughout the world, rates of albuminuria and diabetic kidney disease (DKD) 
are also increasing [8]. However, signs of renal impairment, such as tubular atrophy and 
interstitial fibrosis, can be found even when an individual is in the pre-diabetic state of 
metabolic syndrome [20].  
Metabolic syndrome is diagnosed in individuals with at least three of the 
following risk factors: hyperglycemia, hypertension, high levels of plasma triglycerides, 
high cholesterol, low plasma HDL concentrations, atherosclerosis, non-alcoholic fatty 
liver disease, abdominal obesity, and endothelial dysfunction [21]. These characteristics 
of metabolic syndrome also increase the risk of developing cardiovascular disease and 
type II diabetes, which then increase the risk of renal dysfunction and subsequent failure. 
According to a study by Deji et al. (2009), the mechanisms leading to the development of 
CKD in subjects with metabolic syndrome are not well-understood [3]. A multitude of 
mechanisms have been proposed as being both causes and symptoms of renal damage: 
inappropriate activation of the intrarenal renin-angiotensin-aldosterone system (RAAS), 
hyperglycemia, decreased GFR, visceral adiposity, hypertension, impaired endothelial 
function, insulin resistance, proteinuria, oxidative stress, and advanced glycation end  
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products [9,17,18,22,23]. Many of these changes to normal bodily functions are also risk 
factors for cardiovascular disease and diabetes.  
Oxidative stress is defined as a systemic imbalance between radical oxygen 
species (ROS) and the antioxidants that prevent the ROS from causing cellular damage. 
Chronic inflammation and oxidative stress are understood to exacerbate each other, 
leading to systemic damage [19].  
Hyperglycemia also initiates multiple pathways that lead to the accumulation of 
extracellular matrix proteins and fibrosis. As fibrosis severity increases, so does nephron 
necrosis, resulting in interstitial scarring that impairs renal function [24]. Being able to 
detect signs of renal disease before DKD, CKD, or diabetic nephropathies develop fully 
is vital to the future health of individuals worldwide.  
Rats are often used as a model of obesity and metabolic syndrome due to 
similarities and homology between the genomes of rats and humans; rats have also been 
shown to readily gain weight when fed a HFD. Prior studies completed in the Sweazea 
laboratory and by others have shown that a model of metabolic syndrome can be 
developed by feeding rats a HFD for as few as six weeks [7,25]. Figure 2, adapted from 
Chalmers, Kaskel, and Bambgola (2006), illustrates the relationship between metabolic 
syndrome, insulin resistance, and CKD [26]. 
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Visceral Adiposity  
Adipose tissue is a highly active endocrine organ. Adipose cells secrete 
adipokines, which can act as both pro-inflammatory and anti-inflammatory factors. 
Visceral adipose cells are more resistant to leptin, more sensitive to lipolytic hormones, 
contain a higher triglyceride content than peripheral fat stores and are more lipolytically 
active than subcutaneous fat [27]. The lipolysis of triglycerides in visceral adipose tissue 
releases free fatty acids into the portal vein where they are then transported to the liver 
[28]. Insulin acts to suppress glucose production in two ways: via direct action upon the 
liver or indirectly through free fatty acids. Hyperinsulinemia, high blood insulin 
Figure 2 – Metabolic syndrome, insulin resistance, and CKD.  
The increased visceral adipose tissue associated with metabolic syndrome promotes a 
variety of pathologies including insulin resistance, dyslipidemia, and endothelial 
dysfunction, which contribute to hypertension and chronic kidney disease [26]. 
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concentrations, normally represses lipolysis and the release of free fatty acids; however, 
visceral adiposity has shown resistance to the antilipolytic effects of insulin. Therefore, 
when excess free fatty acids reach the liver through the portal circulation, they interfere 
with the mechanism by which insulin normally inhibits hepatic glucose output [29]. An 
excess of free fatty acids from obesity and increased visceral fat stores negatively impacts 
insulin-glucose balance within the body.  
Upregulation of fatty acid synthase with CKD increases triglyceride synthesis, 
which, due to impaired triglyceride transportation, leads to fat accumulation in the liver, 
(i.e. hepatic steatosis or non-alcoholic fatty liver disease), a co-morbidity of diabetes. 
Similarly, renal steatosis has also been associated with high levels of visceral adiposity 
[30]. Steatosis of these organs and the adipokines released by the infiltrating 
macrophages can lead to liver and renal dysfunction. Leptin, resistin, visfatin, tumor 
necrosis factor alpha (TNFα), interleukin 6 (IL-6), angiotensin II, and adiponectin are 
common adipokines released by adipose tissue. In a healthy state, adiponectin (an anti-
inflammatory and anti-proteinuric adipokine) expression is balanced with TNFα and 
angiotensin II (pro-inflammatory adipokines) levels [18,27,31]. The increased 
macrophage infiltration of adipose cells can disrupt this balance, leading to increased 
secretion of pro-inflammatory factors (i.e. TNFα and angiotensin II) and the promotion of 
inflammation, oxidative stress, endothelial dysfunction, and ultimately CKD [32,33].  
Chronic inflammation is often associated with multiple disease states and has 
been hypothesized to contribute to both morbidity and mortality in CKD patients [33]. 
Studies on animals fed HFDs have found lipid accumulation in the glomeruli and 
proximal tubules of kidneys along with increased expression of inflammatory markers, 
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particularly TNFα and IL-6 [3,27]. Figure 3, adapted from Rüster and Wolf (2013), 
exemplifies this relationship. 
 
 
Foster et al. (2011) conducted a study on participants from the Framingham Heart 
Study (n = 2923) that examined the relationship between renal fat accumulation, 
hypertension and CKD. Participants were assessed for renal fat by computed 
tomography. Their results indicated positive associations between fatty kidney and 
hypertension and between fatty kidney and CKD. After adjusting for visceral adipose 
tissue, no association was found between fat infiltration in the kidney and diabetes. These 
Figure 3 – Relationship between major adipokines and CKD. 
Adipokines secreted by adipose tissue include leptin, tumor necrosis factor alpha 
(TNFα), interleukin-6 (IL-6), and angiotensin II, all of which can initiate and promote 
inflammation, endothelial dysfunction and oxidative stress. These factors promote 
chronic kidney disease. [27]. 
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data indicate that there may be an independent association between hypertension, renal 
fat accumulation, and CKD [23]. Ectopic fat accumulation in the kidneys may constrict 
the renal vein and artery and thereby cause hypertension. Both human and animal studies 
have shown renal fat accumulation caused by HFDs [34-36].  
Sweazea et al. (2010) have demonstrated that a HFD (60% fat) for six weeks 
created a model of metabolic syndrome in young male Sprague-Dawley rats. The HFD 
rats show signs of significant visceral adiposity as well as increased plasma TNFα and 
lipid peroxidation. As discussed, other studies have shown that increased visceral 
adiposity, endothelial dysfunction, hypertension, inflammation and oxidative stress 
(characteristics shared by these animals) increase blood pressure in the kidneys and 
promote renal damage, although this has yet to be examined in the six week HFD rat 
model.   
 
Obesity and High Fat Diets (HFDs) on Renal Function 
Many studies that have shown that HFDs induce obesity in rats [4,23,30,37]. 
Altunkaynak et al. (2008) found that feeding adult female Sprague-Dawley rats a HFD 
(30% fat) for twelve weeks caused the rats to become overweight [4]. These rats then 
developed increased kidney mass, along with significant morphological changes 
indicative of renal disease. Others have shown that feeding spontaneously hypertensive 
rats a HFD (58% fat) results in hypertension, lipid infiltration and increased markers of 
inflammation in the kidneys [5]. 
Aside from the damaging effects of hyperglycemia, endothelial dysfunction, and 
hypertension associated with metabolic syndrome, obesity itself has been shown to 
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increase the risk of developing CKD 3-4-fold [38]. HFDs can disrupt the balance between 
lipogenesis and lipolysis in the kidney, thereby leading to increased renal lipid 
accumulation and lipid peroxidation [23,37]. The fat accumulation caused by the HFD 
can then lead to endothelial dysfunction and over-expression of inflammatory factors, 
fibrosis, hypertension, and oxidative stress [27].  
Deji et al. (2009) conducted a study in which 1.5 month old mice were fed a HFD 
(60% fat) for twelve weeks. The mice developed hypertension, elevated plasma insulin 
and glucose concentrations, proteinuria, changes in kidney morphology, and renal 
steatosis as evidenced by microscopy [3]. The mice had increased renal mRNA 
expression of renin, ACE, and angiotensin, which may lead to dysfunction of the RAAS. 
Additionally, Deji et al. (2009) discovered evidence that obesity induced by the HFD, as 
opposed to the consumption of a HFD itself, may cause a majority of the renal damage. 
This evidence is interesting, as being overweight has been correlated with increased risk 
of developing CKD; perhaps it is the increased adiposity along with the associated 
increase in adipokines specifically, as opposed to the weight itself, that increases CKD 
risk [38]. 
Kume et al. (2007) found that mice fed a HFD (45% fat) developed insulin 
resistance at four weeks, renal steatosis at eight weeks, and renal injury at sixteen weeks 
of diet consumption [37]. Unsurprisingly, the damage to the kidneys increased with 
continued stress and insulin resistance. It is important to note that changes to normal 
renal function began with insulin resistance after only four weeks of the HFD. 
Borst and Conover (2005) fed young Wistar rats a diet of 50% total calories from 
fat for 39 days and found that the rats doubled their visceral and subcutaneous fat content 
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without significantly altering their body weight, muscle mass, or serum free fatty acid 
content [32]. They further found a correlation between insulin resistance in the HFD rats 
and increased expression of the pro-inflammatory cytokine TNFα in muscle, liver and fat 
tissues. Again, these findings suggest that increased adipose tissue may be of more 
importance in creating a pro-inflammatory environment than body mass itself.  
Stemmer et al. (2012) compared lean chow-fed Wistar rats with HFD-fed rats that 
were classified as either sensitive or partially resistant to diet induced obesity after eleven 
months of the HFD (40% fat). A positive correlation was established between levels of 
adiposity and the severity of renal damage. Their results indicate that lipotoxicity is not a 
strong contributor to renal dysfunction as they found plasma triglyceride and free fatty 
acid as well as renal triglyceride levels did not differ significantly between the treatment 
and control groups [30].  Rather, they discovered hyperleptinemia, monocyte infiltration, 
augmented expression of inflammatory cytokines in adipocytes (particularly IL-6 and 
TNFα), and increased expression of pathways leading to renal carcinogenesis [30]. 
 
Markers of Morphological Changes from Renal Disease 
High fat intake has been shown in multiple studies to induce an over-
weight/obese, pre-diabetic state leading to impaired renal function in animal models. 
Morphological changes found in studies include glomerular lesions, accumulation of 
extracellular matrix proteins, dilation of glomerular capillaries, enlarged lumens in the 
tubules and Bowman’s space, mononuclear cell infiltration in the renal cortex, nephron 
degradation and basal membrane thickening of the glomeruli and tubules [3,4]. 
Specifically in cases of obesity-induced kidney damage, both focal and segmental 
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glomerulosclerosis (the scaring or hardening of the glomeruli) and glomerulomegaly 
(abnormal glomerular enlargement) are found [18]. Additionally, the necrosis of renal 
interstitial cells and tubules, shortened epithelium of the tubules, and increased renal 
mass have been observed as markers of damage [3,4].  
Increased adipose and macrophage infiltration and renal hypertrophy are likely 
responsible for the increased mass of damaged kidneys [4,23,30]. The kidneys of diabetic 
Sprague-Dawley rats have been found to double in size only four weeks after induced 
diabetes [39]. The increases in renal volumes of HFD-consuming rats have been 
attributed to inflammation, vasodilatation and connective tissue enlargement initiated by 
the HFD. Edema caused by mononuclear cell infiltrations of the renal tubules may also 
be responsible for volumetric increases in kidney mass [4]. The infiltration of adipocytes 
promotes the secretion of proinflammatory cytokines such as TNFα, which can also be 
measured as a marker of renal damage [40]. 
Altunkaynak et al. (2008) used stereology to calculate the volume of the cortex, 
medulla, glomeruli, and tubules of adult female Sprague-Dawley rats fed a HFD (30% 
fat) for 12 weeks. This study was unique in that it used the relatively new technology of 
stereology in order to quantify renal morphology in terms of kidney volume, surface area, 
cortex volume, number and length of glomeruli, and surface area and number of 
glomerular capillaries [4]. These stereological techniques indicated that morphological 
damage was caused by the HFD. They also found inflammation, increased connective 
tissue within the kidneys, dilatation of glomerular capillaries, and tubular defects causing 
renal deformities [4]. 
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Renin-Angiotensin-Aldosterone System (RAAS) Activation 
Renal dysfunction may be related to the abnormal regulation of RAAS, 
components of which can be found throughout the kidney [3,5,17,18,21,27]. Angiotensin 
II, however, is found only in limited kidney regions and is responsible for increasing 
blood pressure through vasoconstriction. Intrarenal RAAS is regulated by mechanisms 
distinct from those that control circulatory RAAS, as indicated by the higher 
concentrations of RAAS components and angiotensin II in the kidneys compared to 
plasma concentrations. HFD has been shown to significantly increase the mRNA 
expression of renin, ACE, and angiotensin in the kidneys of mice, which activates the 
RAAS system, and can be a mechanism for both renal injury and hypertension [3].  
Additionally, hyperglycemia and overt levels of albuminuria have been shown to 
upregulate intrarenal RAAS; these factors may be an aspect of the pathogenesis of both 
hypertension and renal dysfunction [5]. Angiotensin II in particular has been related to 
obesity and can be linked to hypertension, dyslipidemia, and insulin resistance, which 
together, cause obesity-related kidney disease [22]. Angiotensin II is the final effector of 
the RAAS and can act as both a profibrogenic and pro-inflammatory cytokine; therefore, 
inappropriate levels of angiotensin II can cause renal damage [22,27]. 
Prior studies in the Sweazea laboratory have shown that six weeks of HFD leads 
to impaired endothelium-mediated vasodilation [6]. Since upregulation of the RAAS may 
contribute to endothelial dysfunction it is reasonable to suspect that the rats fed a HFD 
may have evidence of renal disease [41]. 
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Oxidative Stress and Renal Disease 
Oxidative stress is caused by an imbalance between ROS and the antioxidants that 
scavenge them. ROS, which include singlet oxygen, hydroxyl radicals, superoxide anion 
radicals, and hydrogen peroxides, are able to oxidize nucleic acids, lipids and proteins 
causing a chain reaction of damage [42,43]. Normal intracellular metabolic processes, 
such as cellular respiration, constantly produce ROS as by-products [42,44]. Under 
normal physiological conditions, a balance between ROS and cellular defense 
mechanisms (such as antioxidants) maintains homeostasis and prevents oxidative 
damage. External factors, such as smoking, radiation, and alcohol intake, as well as 
diseases such as diabetes, metabolic syndrome, and hypertension can lead to 
overproduction of ROS or underproduction of antioxidants, ultimately resulting in 
damage to cells, tissues, and even DNA. Kidneys are especially susceptible to oxidative 
stress due to a high concentration of long-chain polyunsaturated fatty acids, which easily 
undergo lipid peroxidation when exposed to ROS [43]. 
Oxidative stress and overproduction of ROS are initiated through multiple 
pathways that can be related to the model of increased adiposity created in the Sweazea 
laboratory. Obesity-initiated sources of oxidative stress include: hyperglycemia, tissue 
lipid accumulation, insufficient antioxidants, overproduction of ROS and chronic 
inflammation [45]. Adiposity and pro-inflammatory markers are specifically associated 
with oxidative stress across disease states [27]. HFD-induced obesity increases oxidative 
stress in hepatic, cardiac, and renal tissues by decreasing the enzyme activities of 
antioxidants such as glutathione, as shown by increased lipid peroxidation [45]. Renal 
injury has also been increased by macrophage infiltration and the release of cytokines 
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such as TNFα [43]. Oxidative stress is a key regulator in the pathway of hypertension to 
renal failure. The genetic damage caused by oxidative stress has been proposed by 
Stayanova et al. (2010) as a mechanism of renal damage in human patients with chronic 
renal failure [46]. Advanced glycation end products also increase during end-stage renal 
failure and induce oxidative stress. Additionally, hyperglycemia produces ketoimine and 
ketoamine adducts during glycoxidation and glycosylation, which then produce ROS 
[47]. Figure 4 below was adapted from Vincent and Taylor (2006) and illustrates the 
relationships between obesity and oxidative stress [48].  
 
Figure 4 - Inflammatory pathways that induce oxidative stress during obesity.  
Adipose tissue associated with obesity induces inflammation, which increases 
adipokine concentrations and the infiltration of leukocytes leading to reactive oxygen 
species (ROS) formation. The product of inflammation is ultimately oxidative damage 
and ROS formation. TNFα = tumor necrosis factor alpha; IL-6 = interleukin-6; CRP = 
C-reactive protein; oxLDL = oxidized low-density lipoprotein; 4 HNE = 4-
hydroxynonenal; MDA = malondialdehyde [48]. 
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Markers of Oxidative Stress 
ROS production cannot be directly measured in organs in vivo and surrogate 
markers are therefore used to assess oxidative stress. 8-hydroxy-2’-deoxyguanosine (8-
OHdG) is a sensitive biomarker of oxidative stress in tissue and body fluids and is a 
major product of damage caused by oxidative stress to DNA. 8-OHdG is produced by 
enzymatic cleavage of the guanine base, the base most prone to oxidation. Oxidative 
stress damages both DNA and RNA and other oxidized guanine species, in addition to 8-
OHdG, which are excreted in the urine. Other species commonly excreted include 8-oxo-
guanine, 8-hydroxyguanine, 8-oxo-deoxyguanosine, 8-hydroxyguanosine, and 8-oxo-
deoxyguanosine. Emerging research demonstrates the importance of measuring multiple 
markers of oxidative stress in body fluids in order to gain a full understanding of 
oxidative damage. Urinary excretion of oxidative stress markers presents a measure of 
oxidative stress throughout the body while plasma oxidative stress measures can indicate 
the functional status of the kidneys themselves [42]. 
Lipid peroxidation is also used as a measure of oxidative stress in tissues. 
Hyperglycemia increases the bioavailability of free fatty acids, which are then prone to 
lipid peroxidation. TNFα generates ROS in tissues, which also increases lipid 
peroxidation, particularly with the polyunsaturated fatty acids in the kidney. Lipid 
peroxidation forms malondialdehyde as an end product, which can then be detected via a 
thiobarbituric acid reactive substance (TBARS) assay, a marker of oxidative damage to 
specific organ tissues that is often examined. Plasma 8-OHdG in male rats has been 
found to have a strong positive correlation with plasma malondialdehyde, indicating the 
connection between DNA oxidation and lipid peroxidation [49,50]. Examining both renal 
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lipid peroxidation and plasma oxidative stress markers will provide a complete analysis 
of oxidative stress in the metabolic-syndrome-like phenotype created by the Sweazea 
laboratory via HFD. Prior studies using the Sweazea laboratory rats used in this study 
have shown significant elevations in plasma TBARS and TNFα following high fat intake 
[6,7].   
 
Cystatin C 
Cystatin C is an amino acid inhibitor of cysteine proteinase and is found in serum, 
urine, synovial fluid, seminal fluid, cerebrospinal fluid, and in all cells of the body [51]. 
Serum cystatin C is filtered through the glomerulus freely and subsequently reabsorbed 
and catabolized by the proximal tubular cells without returning to the blood [52]. Urinary 
changes in cystatin C can be used as markers of acute renal injury, although not often 
used in CKD assessment [53]. Serum creatinine levels are often assessed as a marker of 
renal function, however, more recent studies indicate that serum or plasma cystatin C is a 
stronger, and more consistent, indicator of GFR and renal function [51,54-58]. While 
serum creatinine levels can be affected by sex, age, diet, muscle mass, and body mass, 
cystatin C levels are independent of gender, muscle mass, and malignancy [58]. A meta-
analysis of 54 studies found that serum cystatin C is superior to serum creatinine levels 
with respect to GFR estimation [56]. Moreover, plasma cystatin C has been shown to 
detect early signs of renal dysfunction and is more sensitive in the detection of renal 
function decline [8,51,54,57]. Cystatin C increases during renal disease, even during the 
early stages, and is therefore a highly used biomarker in the early detection of kidney 
disease.  
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Hydrogen Peroxide  
 Hydrogen peroxide (H2O2) is used as a marker of both inflammation and 
oxidative stress and is extremely toxic in vivo [59,60]. The toxicity of H2O2 encourages 
the rapid elimination of H2O2 from the body via urinary excretion or the action of 
glutathione peroxidase, an antioxidant [61]. Urinary and tissue H2O2 levels are often 
examined in studies of renal function. The increased renal perfusion pressure that is 
associated with hypertension has been found to elevate H2O2 excretion [62]. H2O2 has 
also been related to obesity-induced hypertension by studies that have shown that 
activation of the RAAS and secretions of angiotensin II lead to increased H2O2 
production [63].  
 H2O2 is a valuable marker of early renal damage not only because it is used to 
signify inflammation and oxidative stress but also because it has been consistently shown 
to precede proteinuria in the timeline of functional renal damage. Infusing H2O2 directly 
into the renal arteries of Munich-Wistar rats resulted in dose-dependent increases in 
proteinuria, with the excreted proteins originating from the glomeruli [64]. Although 
proteinuria levels were significantly elevated by the H2O2, there were no changes to GFR. 
GFR is considered the gold standard measurement of kidney failure and the 
understanding that H2O2 increases prior to both GFR decline and proteinuria, another 
often-used marker of renal dysfunction, increases the importance of H2O2 as an indicator 
of the initiation of renal pathology [64].  
 HFDs have been shown to increase urinary H2O2 excretion after only one week in 
C57BL/6 mice fed a 60% fat diet. H2O2 levels remained elevated in both 12 and 36 week 
feeding protocols [59,65]. In HFD-fed mice, H2O2 was also shown to increase prior to a 
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more robust inflammatory and fibrotic response as well as urinary protein excretion. 
Because increasing H2O2 concentrations have been consistently shown to precede more 
vigorous responses to HFD-induced renal damage and inflammation, it is an important 
tool to assess indications of future risk for worsening damage. 
 
Biomarkers of Inflammation: TNFα  and IL-6 
The two most commonly studied markers of inflammation are TNFα and IL-6, 
pro-inflammatory cytokines produced by adipocytes and macrophages. HFDs and obesity 
often lead to the infiltration of adipocytes and macrophages into the kidneys where they 
release these cytokines. The presence of both inflammatory markers in HFD-induced 
obesity allows for the classification of obesity as a low-grade inflammatory disease [66]. 
Chronic low-grade inflammation is defined as a 2-3–fold increase in the systemic 
concentrations of both pro-inflammatory and anti-inflammatory cytokines and cytokine 
inhibitors. Initially, cytokines appear in the following order: TNFα, interleukin-1 beta 
(IL-1β), IL-6, interleukin-1 receptor antagonist (IL-1ra), soluble TNF-α-receptors (sTNF-
R), and interleukin-10 (IL-10) [67]. The secretion of IL-6 is initiated by many of the 
same pathways as TNFα and the two biomarkers are often studied in tandem. TNFα and 
IL-6, in addition to other pro-inflammatory cytokines, are understood to promote a state 
of chronic inflammation, which often positively correlates with both increased morbidity 
and mortality in patients with renal disease, although IL-6 is distinct from TNFα [33,68-
70].  
Angiotensin II, advanced glycation end products, and oxidized low-density 
lipoproteins (LDL) can stimulate TNFα synthesis [71]. Several animal studies have 
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shown that the presence of TNFα can increase insulin resistance [32]. TNFα is therefore 
not only a pro-inflammatory cytokine, but also a contributor to CKD by increasing 
insulin resistance, damaging the filtration ability of the kidneys by increasing 
hyperglycemia, and by increasing oxidative stress [32]. As previously mentioned, 
hyperglycemia eventually damages the kidneys resulting in proteinuria, and both 
proteinuria and hyperglycemia have been indicated in the mechanism of inappropriate 
activation of the intrarenal RAAS. Additionally angiotensin II, a component of the 
RAAS, stimulates the secretion of TNFα furthering the cycle of renal damage [3,5,18,22]. 
Reunguli et al. (2008) found that as renal damage in male Sprague-Dawley rats increased, 
so did renal oxidative stress and TNFα levels [72].  
It is important to test for TNFα in tissues as opposed to, or in addition to, serum 
because it has been shown that although TNFα expression can be markedly increased in 
both skeletal muscle and visceral adipose tissue; serum TNFα expression may be 
unaffected [32]. Borst and Conover (2005) demonstrated that feeding young Wistar rats a 
HFD of 50% fat for 39 days led to increased adiposity, insulin resistance, and increased 
tissue expression of TNFα, while serum TNFα levels remained unchanged. Prior studies 
in the Sweazea laboratory’s model of metabolic syndrome created by HFD-feeding of 
male Sprague-Dawley rats (60% fat for six weeks) demonstrates that plasma TNFα as 
well as vascular and plasma oxidative stress were elevated with the short term feeding 
protocol [6,7]. Therefore renal TNFα expression is anticipated to be elevated as well in 
these animals.  
IL-6 acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine; 
its role in inflammation has therefore been considered controversial due to its paradoxical 
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relationship to inflammation. In a pro-inflammatory state, IL-6 is secreted by 
macrophages via nuclear factor kappa beta, a TNFα-involved pathway. However, 
emerging research challenges the role of IL-6 as a pro-inflammatory cytokine with 
evidence that as skeletal muscles contract during physical activity, myocytes produce and 
release IL-6 into circulation, independent of any preceding TNFα release. Both the 
upstream as well as the downstream signaling pathways for IL-6 production differ 
between IL-6 production in macrophages and myocytes [70]. Pederson and Febbraio 
(2008) have found that monocytes specifically are not responsible for the increase in 
plasma IL-6 that has been consistently observed during and post-exercise [68].  
Differences between IL-6 and TNFα are important in understanding their effects 
on metabolism. For example, although both IL-6 and TNFα induce lipolysis, only IL-6 
stimulates fat oxidation. Adipocyte lipolysis induced by TNFα increases circulating free 
fatty acids and forms a direct link between TNFα and insulin resistance, supporting the 
increasing research interest in the hypothesis that TNFα can be directly implicated as 
having a pathogenic role in glucose metabolism contributing to diabetes [68,70,73]. 
Although insulin resistance induced by TNFα has been carefully examined, the part that 
IL-6 plays in the etiology of obesity-induced insulin resistance and hyperglycemia has 
not been elucidated. Figures 5 and 6 diagram the anti-inflammatory effects of IL-6 and 
the pathways by which it increases lipolysis and fat oxidation, stimulates glucose 
production by the liver, and decreases pro-inflammatory TNFα by increasing anti-
inflammation cytokine concentrations. Although TNFα is implicated in the downstream 
signaling pathway of IL-6 production by adipocytes and macrophages, IL-6 has an 
inhibitory effect on TNFα production, leading to speculation that IL-6 may function as a 
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defense mechanism against TNFα or as a compensatory mechanism in cases of insulin 
resistance [68]. A third theory that may explain the paradoxical associations with IL-6 
and both the enhanced insulin action during post-exercise periods and with its association 
with obesity-induced insulin resistance is that there are significant differences between 
the acute elevation post-exercise and the chronic elevation that occurs with obesity. 
Chronic increased IL-6 levels are an indication of continued TNFα production and 
activation of inflammatory pathways. 
 
Figure 5 - Muscular IL-6 secretion and effects on metabolism. 
Interleukin 6 (IL-6) secreted by muscular contraction during exercise induces fat 
oxidation and lipolysis while influencing glucose homeostasis. IL-6 also acts as an 
anti-inflammatory cytokines by inhibiting tumor necrosis factor alpha (TNFα) and 
stimulating the soluble tumor necrosis factor receptor (sTNF-R) [69]. 
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Despite the controversy regarding the differing effects of IL-6 as a cytokine and 
as a myokine, it continues to be studied as a marker of inflammation in HFD-induced 
obesity. The research conducted on the model of visceral adiposity created in the 
Sweazea laboratory investigates the effect of a HFD without exercise and therefore the 
anti-inflammatory properties of IL-6 as a myokine are not of major concern. Studies on 
both overweight and obese women have found that serum TNFα and IL-6 levels were 
positively correlated while Ozay et al. (2014) found that HFD-induced obesity in male 
Wistar albino rats (26% fat for 12 weeks) increased plasma TNFα without altering 
Figure 6 - Biological role of contraction-induced IL-6.  
Exercise causes myokines, such as interleukin 6 (IL-6), to be secreted and released into 
circulation. Blood vessels transport IL-6 to adipose tissue and the liver, where it initiates 
lipolysis and glucose production. Within skeletal muscle, IL-6 signals a gp130Rβ/IL-
6Rα homodimer that activates AMP-kinase and/or phosphatidylinositol 3-kinase and 
increases glucose uptake and fat oxidation. IL-6Rα/gp130Rβ = interleukin-6 homodimer; 
PI3-K = phosphatidylinositol 3-kinase; p-Akt = phosphorylated protein kinase B; p-
STAT3 = phosphorylated signal transducer and activator of transcription 3; p-AMPK = 
phosphorylated AMP-kinase [68]. 
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plasma IL-6, supporting the role of TNFα as a predecessor to IL-6 expression [19,74]. 
Conversely, Kern et al. (2001) found that IL-6 levels in obese human subjects were 
higher in both plasma and adipose tissue compared to TNFα [73]. Additionally, Kern et 
al. (2001) found no relationship between the plasma levels of IL-6 and TNFα while there 
was a strong linear relationship between the expressions of these cytokines in adipose 
tissue. The local effects that TNFα exhibits in a paracrine capacity explain these findings; 
IL-6 in plasma may be of more importance systemically [73]. Stemmer et al. (2012) 
examined the effect of a HFD (40% fat for 11 months) on male Wistar rats and the 
creation of an inflammatory renal environment. Their results indicate an increase of IL-6 
and TNFα in retroperitoneal fat and in the kidneys, while there was no increase in 
circulating IL-6. Aside from the research being conducted in this thesis, Stemmer et al. 
(2012) constitute the sole researchers who have investigated the effects of HFD-induced 
obesity on renal tissue inflammation. This thesis investigates both IL-6 and TNFα protein 
expression via Western Blot analysis whilst Stemmer et al. (2012) utilized real time 
polymerase chain reaction (RT-PCR) to determine mRNA expression. A limitation of 
their methodology is that even with increased mRNA expression, post-transcriptional 
modifications can prevent protein expression in tissues. 
 Regulation of inflammatory markers varies across tissue types, as demonstrated 
by Lamas et al. (2004), who fed young male Wistar rats a cafeteria diet consisting of 62% 
fat, including paté, chips, bacon, chocolate, and biscuits for five weeks. In just five 
weeks, the HFD rats had significant differences in body weight, serum triglycerides, free 
fatty acids, and total cholesterol while serum glucose, total proteins, and insulin remained 
the same across diet groups [75]. This study found that despite the significant effects of 
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the HFD on the aforementioned markers, there was decreased splenic mRNA expression 
of IL-6 and TNFα, a negative correlation between splenic TNFα mRNA and total fat pad 
mass, and no correlation between splenic IL-6 mRNA and total fat pad mass [75]. The 
decreased mRNA expression of both TNFα and IL-6 is contrary to most other HFD 
studies in rats but demonstrates that inflammatory markers can vary widely in different 
tissues. 
 
Rats as a Model of Metabolic Syndrome 
Researching the effects of metabolic syndrome on renal function using an animal 
model requires determining the most appropriate model. There is a wide variety of 
research concerning both metabolic syndrome and renal function in rats, with the 
research varying in terms of diet composition and administration, duration of treatment, 
as well as rodent model, sex, and age. 
Variations in the type of fat used and the duration of feeding in HFD-rodent 
studies change the resulting model of metabolic syndrome and obesity. Buettner et al. 
(2006) examined the effect of the varying fatty acids on 1.5 month old male Wistar rats. 
Rats were randomly assigned to coconut oil (saturated fatty acids), olive oil 
(monounsaturated fatty acids), lard (comparable amounts of saturated fatty acids and 
monounsaturated fatty acids), or fish oil (polyunsaturated fatty acids) and examined for 
morphometric and physiologic differences after twelve weeks. Hematoxylin and eosin 
staining revealed hepatic microvesicular fat deposits and increased liver triglycerides in 
the lard, coconut oil, and olive oil groups but no liver inflammation or fibrosis [76]. 
Sweazea et al. (unpublished observations) similarly found hepatic steatosis after feeding 
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male Sprague-Dawley rats a HFD of 60% lard for six weeks. The lard group in Buettner 
et al.’s (2006) study showed increased plasma insulin and glucagon, increased whole 
body insulin resistance, and decreased plasma adiponectin, making the lard diet a good 
model of insulin resistance. Further supporting the justification for using a HFD 
consisting of a saturated fat such as lard to create a model of metabolic syndrome, 
Buettner et al. (2006) established that lipid synthesis genes, such as fatty acid synthase, 
were upregulated in the lard group while fatty acid oxidation enzymes, such as carnitine 
palmitoyltransferase, were downregulated. Although plasma creatinine was examined as 
a marker of renal function, no changes were found among any diet groups [76]. Stark et 
al. (2000) demonstrated the importance of fatty acid subtype by finding no insulin 
resistance or impaired glucose tolerance after feeding Sprague-Dawley rats a HFD 
consisting of 25% soybean oil, a polyunsaturated fatty acid, for three months [77].  
In order to better classify the appropriate age-diet relationship, de Castro et al. 
(2013) conducted research comparing high fructose (60% total calories from fructose) 
and high saturated fat (40% total calories from fat) diets for 13 weeks on young (4 week 
old) and adult (12 week old) male Fischer rats. Their results concluded that the HFD was 
the most effective diet for inducing metabolic syndrome in young rats [21]. The HFD 
animals developed increased fasting glucose without increased hepatic glycogen, 
indicating that the HFD altered both glucose and hepatic metabolism. Additionally, de 
Castro et al. (2013) demonstrated that the young HFD-fed rats exhibited central obesity, 
increased blood pressure, increased heart rate, and renal inflammatory infiltrates, despite 
serum creatinine and urea levels remaining unchanged. De Castro et al. (2013) conducted  
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their research on Fischer rats in particular, however Sprague-Dawley rats have also been 
shown to be an equally useful animal model of metabolic syndrome [78].  
Pranprawit et al. (2013) write that inducing metabolic syndrome in Sprague-
Dawley rats can be inconsistent based on the type and amount of fat incorporated into the 
diet and the length of study protocol [78]. Although Pranprawit et al. (2013) found that 
eight weeks of HFD (60% total calories from fat, consisting of lard and soybean oil) did 
not induce glucose impairment or increase kidney mass in male Sprague-Dawley rats, 
Jiao et al. (2008) found that male Sprague-Dawley rats consuming a HFD (23% calories 
from fat, consisting of lard) developed insulin resistance in as few as three to four weeks 
[79]. These findings indicate the importance of saturated fat intake in diet-induced-
obesity Sprague-Dawley rats.  
 
Conclusion  
 HFDs have been examined in rodent models to determine dietary influences on a 
myriad of disease pathologies. When examining the effect of high fat feeding on renal 
structure and function, the majority of studies examine long term feeding protocols. 
Studies of the effects of shorter term feeding protocols to mimic early onset pathological 
changes resulting from HFDs are not evident in the literature. Research using a variety of 
rodent models has investigated the effects of a HFD from eight weeks to 11 months, and 
although kidneys have been examined at four weeks, there are no studies that have fully 
examined the effects of shorter term feeding protocols on renal function [3-5,30,76,78]. 
Renal dysfunction has been shown to be highly associated with uncontrolled diabetes and 
HFDs can induce the pre-diabetic state of metabolic syndrome in as short a time as six 
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weeks, as demonstrated by the model created in the Sweazea laboratory. The Sweazea 
model, and this study, are unique in that they represent the shortest feeding protocol in 
HFD-fed rodent renal studies.  
Studies throughout the literature have examined HFDs ranging from 30% total 
calories from fat to 60% total calories from fat and a variety of animal models have been 
used to examine the effect of such diets on obesity, hypertension, metabolic syndrome, 
renal function, oxidative stress, and markers of inflammation. Few studies look at all of 
these factors together, and how the kidney is affected, after a short period of time. Prior 
studies by the Sweazea laboratory have shown that young (1.5 month old) male Sprague-
Dawley rats fed HFD (60% total calories from fat, consisting primarily of lard) for six 
weeks develop metabolic syndrome: increased body fat, high blood glucose 
concentrations, impaired glucose tolerance, hypertension, endothelial dysfunction, 
oxidative stress, and inflammation [6,7]. Unpublished observations from the laboratory 
also demonstrate that these animals develop hepatic steatosis. The research conducted on 
this model of increased adiposity will examine not only a shorter term feeding protocol 
than other studies but will also study a wide variety of renal structural and functional 
markers. In order to fully assess renal status in the HFD-fed rats, animal morphometrics, 
renal mass, renal morphology, renal lipid infiltration, proteinuria, urinary cystatin C, 
urinary hydrogen peroxide, renal tissue TNFα and IL-6 protein expression, renal lipid 
peroxidation, and urinary markers of oxidative DNA damage were all studied. No other 
studies evident in the literature examine either a six week feeding protocol or such a 
variety of markers. This study is novel in that it presents a full picture of the effects of the 
relatively short term HFD feeding regime on renal function and structure. The etiology of 
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increased adiposity in relation to renal dysfunction is not fully understood and this study 
allowed for a greater understanding of the changes induced with a short feeding protocol. 
Additionally, only Stemmer et al. (2012) have previously studied renal tissue 
inflammation caused by a high fat feeding; this study protocol examined both TNFα and 
IL-6 and is unique for doing so. 
The summation of current literature on the HFDs and renal dysfunction supports 
the hypothesis that even during the early stages of metabolic syndrome, the kidneys begin 
to develop signs of stress and damage, which can eventually lead to diabetic nephropathy, 
diabetic kidney disease, and ultimately end-stage renal disease. Understanding the 
etiology of damage related to poor nutrition is vital to the prevention and treatment of 
renal failure.  
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CHAPTER 3 
MATERIALS AND METHODS 
Animal Models 
 The animal models used in this study were male 1.5 month old Sprague-Dawley 
rats [140-160 g body weight, Harlan Takland Industries (Madison, WI, USA)] fed a HFD 
(60% kcal from fat; Research Diets Inc; Appendix A) for six weeks. These rats were 
already known to have developed metabolic syndrome, increased body fat, high blood 
glucose concentrations, endothelial dysfunction, hypertension, plasma and vascular 
oxidative stress and hepatic steatosis, based upon previous studies conducted in the 
Sweazea laboratory [6,7]. The kidneys, plasma, and urine of the rats fed the HFD were 
compared with 1.5 month old male Sprague-Dawley rats fed a standard rodent chow (5% 
fat), both of which were available from prior studies. All rats were fed either the HFD or 
chow diet for six weeks with the food replaced every three to four days. All rats were 
provided with unlimited access to food and water, housed in pairs in identical cages at the 
same facility and provided 12 hours of light and 12 hours of dark per day. The prior 
studies from which the tissues samples were obtained were approved by Arizona State 
University’s IACUC (Protocol 09-1045R). 
 
Study Design 
 The study design was a true experiment with a treatment (HFD) and control group 
(standard rodent chow). Rats were randomized to six weeks of either chow or HFD. At 
the end of the six weeks, sodium pentobarbital (200 mg/kg, i.p.) was used to euthanize all 
rats. Blood, urine, and kidney samples were then collected. The blood samples were 
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obtained via cardiac puncture and centrifuged at 13,000 rpm at 4ºC for 15 minutes to 
separate formed elements from the plasma, which was then stored at -80ºC until analyses. 
Urine was collected with a 25-gauge needle inserted directly into the bladder. The urine 
was then centrifuged at 13,000 rpm at 4ºC for 10 minutes to remove debris and the 
supernatant was then stored at -80ºC until analyses. Following a midline laparotomy, a 
subset of kidneys were removed and stored at -80ºC until analyses while a separate subset 
was embedded in Optimal Cutting Temperature (OCT) compound prior to freezing.  
Table 1, below, indicates the animal subsets that were used in each aspect of this 
study design. 
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Table 1 – Summary of Animal Subsets 
Diet/ 
Animal 
ID 
Date of 
Sample 
Collection 
Urine 
Protein 
(BioRad) 
Urine 
Creatinine 
(to 
normalize 
protein) 
Renal 
Morphology/ 
Oil Red O 
Renal 
Mass 
Body Mass, 
Tail Length, 
Waist 
Circumference, 
% Fat 
Renal 
tissue 
TNFα  and 
IL-6  
Protein 
Expression 
Plasma 
Cystatin 
C 
Renal 
TBARS 
Plasma 
OxDNA
/RNA 
Urine 
H2O2 
Chow 
/C1 09/08/09             X     X 
Chow 
/C2 09/09/09                 X X 
Chow 
/C5 09/28/09     X X X           
Chow 
/C6 09/29/09     X X X X X   X   
Chow 
/C7 10/12/09       X X X X X X   
Chow 
/C8 10/13/09 X X X X X X X X X   
Chow 
/C9 10/14/09     X X X   X X   X 
Chow 
/C10 10/15/09 X X         X   X X 
Chow 
/C11 11/11/09 X X   X X X X   X   
Chow 
/C12 11/12/09 X X         X X X   
Chow 
/C13 11/13/09 X X X X X X X X X   
Chow 
/C14 12/14/09     X X X X X   X X 
Chow 
/C15 12/15/09 X X   X X X     X   
Chow 
/C18 04/09/10                   X 
Chow 
/C21 04/29/10 X X                 
Chow 
/C22 05/06/10 X X                 
            
HFD 
/HF3 09/25/09             X       
HFD 
/HF4 09/24/09                   X 
HFD 
/HF5 10/07/09             X   X   
HFD 
/HF7 10/09/09 X X X       X   X   
HFD 
/HF8 11/02/09 X X         X       
HFD 
/HF9 11/04/09     X X X X X X X   
HFD 
/HF10 11/05/09 X X X X X X X   X   
HFD 
/HF11 11/06/09 X X X X X X X X X   
HFD 
/HF12 11/30/09       X X X X   X X 
HFD 
/HF13 12/01/09     X X X X X   X X 
HFD 
/HF14 12/07/09       X X X   X     
HFD 
/HF15 12/08/09       X X X X X   X 
HFD 
/HF16 12/09/09 X X   X X X   X X   
HFD 
/HF17 04/01/10 X X                 
HFD 
/HF18 04/02/10 X X                 
HFD 
/HF21 04/30/10                   X 
HFD 
/HF22 05/04/10                   X 
HFD 
/HF24 05/10/10 X X                 
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Laboratory Analysis 
Kidney Morphology 
Kidneys from rats fed either a standard rodent chow (5% fat) or HFD (60% fat) 
for six weeks were available from prior studies. Animal morphometrics (body mass, 
epididymal fat pad mass, waist circumference, tail length) and renal tissue masses were 
measured in a subset of animals (n = 9 chow and n = 8 HFD animals). Gonzales et al. 
(2000) have confirmed that tail length can be used as marker of overall growth in rats 
[80]. Waist circumferences were measured with a fabric tape measure positioned at the 
iliac crest. 
Another subset of frozen kidneys (n = 4 chow and n = 5 HFD rats) were 
embedded in OCT compound and sectioned using a cryostat (Leica Biosystems CM1950; 
Buffalo Grove, IL). Sections of embedded tissues (14µm) were collected onto glass 
microscope slides, stained with hematoxylin and counterstained with eosin (Appendix C). 
Sections were viewed using a light microscope (Olympus BX50) and images collected 
with an Olympus DP70 camera (Melville, NY) to assess morphology. It was predicted 
that kidneys from HFD rats would have increased mass and morphological changes 
consistent with kidney disease.  
In order to determine the level of fat infiltration, a subset of OCT-embedded 
frozen kidneys (n = 4/group) were sectioned into 14µm sections. Frozen sections were 
collected onto glass microscope slides and stained with Oil Red O using a commercially 
available kit (Cat. No. ORK-2-IFU; ScyTek Laboratories, Logan, UT; Appendix D). 
Sections were counterstained by exposure to hematoxylin. Images were collected using 
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the same microscope set-up as described above. It was predicted that kidneys from HFD 
rats would have increased fat, consistent with the development of kidney disease.  
 
Biomarkers of Renal Function 
A random set of rat urine from prior studies was used determine urine protein 
concentrations (n = 8/group), which were measured using the Bradford technique (Bio-
Rad, Hercules, CA). Aliquots of diluted urine (1:500) were mixed with Bradford Reagent 
(4:1; Bio-Rad, Hercules, CA). The mixture was loaded into a 96-well plate in duplicate 
and read at 595nm using a plate reader. The absorbance of the samples were compared to 
a bovine serum albumin standard curve (0, 20, 40, 60, 80, 100 µg/µL total protein) to 
determine the concentration of protein in each urine sample. There is no gold standard for 
the measurement of proteinuria and the methods of detection have large variability. 
According to the National Kidney Foundation, proteinuria should be assessed by either a 
24-hour urine collection, during which creatinine content should also be measured, or by 
spot urine protein:creatinine ratio [16]. The same set of urine samples used to quantify 
urine protein were used to ascertain urine creatinine concentrations (n = 8/group) using 
an available kit (Cat. No. CR01; Oxford Biomedical Research, Rochester Hills, MI; 
Appendix E). Aliquots of urine were diluted (1:10) and prepared according to kit 
instructions then loaded into a 96-well plate in duplicate and read at 490nm. Creatinine 
concentrations were calculated from a known standard curve. It was predicted that HFD 
would increase urinary protein:creatinine concentrations, indicating that the filtering 
system of the kidney was damaged, resulting in leakage of proteins into the urine. 
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Plasma cystatin C, a sensitive biomarker of renal function, was measured using an 
available ELISA kit (Cat. No. MSCTCO; R&D Systems, Minneapolis, MN; Appendix 
F). Random samples of rat plasma available from prior studies (n = 10/group) were 
diluted 400-fold and prepared according to kit instructions in a 96-well plate in duplicate. 
The absorbances of the samples were read at 450nm, corrected with a reading at 540nm, 
then compared to a standard curve (0, 125, 250, 500, 1000, 2000, 4000, 8000 pg/mL rat 
cystatin C standard) to determine the plasma concentrations of cystatin C. It was 
predicted that HFD would increase cystatin C, indicating early renal dysfunction. 
Urinary H2O2, a biomarker of inflammation, oxidative stress, and renal function 
was measured using an available kit (Cat. NO. ab102500; Abcam, Cambridge, MA; 
Appendix G). Random samples of rat urine (n = 6/group) were diluted (1:2 or 1:4 based 
on amount of available sample) and prepared according to kit instructions and loaded into 
a 96-well plate in duplicate. Sample absorbances were then read at 570nm and compared 
to a standard curve in order to quantify H2O2 concentrations. H2O2 levels were then 
normalized to creatinine concentrations. Urinary creatinine concentrations on the same 
urine samples (n = 6/group) were assessed using a kit (Cat. No. CR01; Oxford 
Biomedical Research, Rochester Hills, MI). Aliquots of urine were diluted (1:20 or 1:40 
based on amount of available sample) and prepared according to kit instructions. Samples 
were then loaded into a 96-well plate in duplicate and read at 490nm and concentrations 
were calculated from a known standard curve. It was predicted that HFD would increase 
urinary H2O2:creatinine concentrations, indicating early renal functional damage.  
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Inflammatory Markers 
Briefly, a subset of kidneys from both chow and HFD rats were transferred to a 
ground glass homogenizer containing Tris-HCI buffer [10 mM Tris (pH 7.6; Cat. No. 
161-0716; Bio-Rad, Hercules, CA), 1 mM EDTA, 1% triton X-100, 0.1% Na-
deoxycholate, 0.03% protease inhibitor cocktail (Cat. No. P2714; Sigma-Aldrich, St. 
Louis, MO), and 1 mM phenylmethanesulfonyl fluoride (PMSF)]. Samples were then 
centrifuged at 14,000 rpm for 10 minutes at 4°C. Total protein concentrations of the 
supernatants were determined using the Bradford Technique (Bio-Rad, Hercules, CA). 6 
µL of 5X SDS sample buffer that includes 2% β-mercaptoethanol as a reducing agent 
was added to sample supernatant and boiled for 3 minutes. Supernatant (100 µg total 
protein/lane) was resolved using 4-15% gradient Tris-HCl SDS-PAGE gels (Cat. No. 
456-1083; Bio-Rad, Hercules, CA) and transferred to PVDF membranes (Cat. No. 152-
0176; Bio-Rad, Hercules, CA) for 90 minutes at 200 V. Membranes were blocked for two 
hours in Tris buffered saline containing Tween 20, BSA fraction VI, and 5% nonfat milk 
followed by an overnight incubation at 4°C in primary antibodies specific for IL-6 
(1:250; Cat. No. ab6672; abcam, Cambridge, MA; Appendix H), TNFα (1:500; Cat. No. 
11948; Cell Signaling, Danvers, MA; Appendix I) and beta-actin (1:2000; a loading 
control; Cat. No. ab8227; abcam, Cambridge, MA; Appendix J). Primary antibodies were 
prepared in Tris buffered saline with Tween 20 (500 µL in 1 L Tris buffered saline), 
Membranes were then exposed to anti-rabbit IgG secondary antibody in Tris buffered 
saline for one hour at room temperature (1:1000 for IL-6 and TNFα and 1:2000 for beta-
actin; Cat No. 7074S; Cell Signaling Technology, Danvers, MA) followed by exposure to 
Pierce enhanced chemiluminescence western blotting substrate (Cat. NO 32279; Thermo 
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Scientific, Rockford, IL). Immunoreactive bands were visualized by exposure to x-ray 
film (Cat. No. 34090; Thermo Scientific, Rockford, IL) and analyzed using NIH ImageJ 
software. Protein expressions of IL-6 and TNFα were normalized to beta-actin to 
determine the level of IL-6 (n = 5 chow and 6 HFD animals) or TNFα (n = 8/group) in 
each sample. 
 An ELISA was used to quantify TNFα concentration in renal tissue supernatant 
(Cat. No. ER3TNFA; Thermo Scientific, Rockford, IL; Appendix K). A subset of 
kidneys was randomly selected and 50-100 mg of individual kidneys (n = 5/group) were 
homogenized with phosphate buffer saline (PBS), 1 mM pH (7.4) solution using a ground 
glass homogenizer. Diluted renal tissue samples (1:1) were prepared according to kit 
instructions, loaded into a 96-well plate in duplicate, and absorbances were read at 
450nm and corrected to a reading at 550nm. Corrected absorbance readings were then 
compared to a standard curve (0, 31, 93, 278, 833 pg/mL rat TNFα standard) in order to 
establish renal TNFα concentrations.  
 
Oxidative Stress 
The same subset of samples used for the TNFα ELISA (n = 5/group) were used to 
evaluate renal oxidative stress via lipid peroxidation levels using a TBARS assay (Cat. 
No. 0801192; ZeptoMetrix Corporation, Buffalo, NY; Appendix L). Samples were 
prepared according to kit instructions then boiled at 95ºC for one hour and subsequently 
put on ice for ten minutes. Samples were then centrifuged at 3,000 rpm for 15 minutes at 
room temperature. The supernatant was then collected and centrifuged at room 
temperature for 15 minutes at 3,000 rpm. The supernatant was again collected and loaded 
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into a 96-well plate in duplicate.  The absorbance of the supernatant were read at 540nm 
and compared to a standard curve (0, 12.5, 25, 50, 100 nM/mol MDA) to determine renal 
tissue concentrations of lipid peroxidation. Lipid peroxidation levels were predicted to be 
elevated by HFD, indicating increased oxidative stress in the kidneys of HFD-fed rats. 
Plasma 8-hydroxyguanosine, 8-OHdG, and 8-hydroxyguanine were examined as 
biomarkers of oxidative DNA/RNA damage using a commercially available kit, as 
oxidative stress has been shown to be elevated early during renal failure (Cat. No. 
589320; Cayman Chemical, Ann Arbor, MI; Appendix M) [3]. Plasma samples were 
selected from prior studies (n = 10 chow and n = 11 HFD animals) and filtered with a 
30kDa filter (Cat. No. UFC503096; EMD Millipore, Billerica, MA), diluted 1:25, 
prepared according to kit instructions, loaded into a 96-well plate in duplicate and 
absorbances were read at 410nm. Plasma oxidative DNA/RNA damage was quantified by 
comparing absorbances to a standard curve. Oxidative stress markers were expected to be 
elevated, indicating that oxidative DNA/RNA damage was initiated by the HFD. 
 
Variables 
 A number of variables were used to assess the effect of HFD on kidney structure 
and function. The independent variable was classified as the diet each animal group 
consumed: either the HFD (20% kcal from protein, 20% kcal from carbohydrates, and 
60% kcal from fat; Appendix A) or the standard rodent chow (18.9% kcal from protein, 
57.33% kcal from carbohydrates, and 5% fat; Appendix B). 
Morphometrics of the animals were available from prior studies and used to 
analyze the diet groups for differences in body mass, epididymal fat pad mass, waist 
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circumference, and tail length. This sample of animals was also used to assess renal tissue 
masses. Morphological changes were further evaluated by inspecting sections of kidney 
tissue under a light microscope for renal damage and by staining sections with Oil Red O 
to assess the level of fat infiltration. 
 Proteinuria was examined by the Bradford technique (Bio-Rad, Hercules, CA) to 
measure the concentrations of urinary protein and creatinine and by then normalizing 
protein concentrations to creatinine. The protein:creatinine ratios of the chow and HFD-
fed rats were compared for mean differences. Proteinuria is considered an early marker of 
renal dysfunction, as it is a sign of pathologically leaky kidneys.  
Plasma cystatin C is also a marker of early kidney disease and a kit was used to 
quantify plasma concentrations.  
An available kit was used to quantify urinary H2O2, which were normalized to 
urinary creatinine concentrations in the same animals.   
Renal TNFα were assessed using Western blots and a commercially available 
ELISA in order to determine renal inflammation. Western blots were used in order to 
analyze IL-6 expression in renal tissue.   
Plasma oxidative DNA/RNA damage and renal tissue lipid peroxidation were 
examined as markers of oxidative stress. Plasma oxidative DNA/RNA damage was 
determined using a competitive kit and renal tissue lipid peroxidation was quantified via 
a commercially available TBARS kit. 
 Together, these variables served to quantify the level of kidney damage inflicted 
by the short term HFD.  
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Statistical Analysis 
Data are expressed as mean ± SEM. Statistical analyses were computed using 
SigmaPlot (Systat Software Inc, Version 13.0; San Jose, CA). Data were tested for 
normality and were then analyzed using either Student’s t-tests or Mann-Whitney U tests. 
Values of p < 0.05 were considered significant.  
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CHAPTER 4 
RESULTS 
Structural Changes 
Morphometrics 
Although the HFD rats tended to weigh more than the chow-fed rats, this 
difference was not statistically significant (Figure 7). Rats fed a HFD demonstrated 
significantly increased epididymal fat pad mass compared to chow-fed animals, 
establishing that adiposity was increased by the HFD (Figure 8). The waist 
circumferences of the HFD animals were significantly increased when compared to chow 
fed controls, indicating that the HFD caused increases in abdominal adiposity (Figure 9). 
The tail lengths, a marker of overall animal growth, of the HFD and chow-fed animals 
were not significantly different (Figure 10).  
The renal masses of the HFD rats were significantly elevated compared to the 
renal mass of the chow group (Figure 11).  
 Morphological analyses using hematoxylin and eosin stained tissue sections 
showed no structural differences between the chow and HFD groups, indicating that 
although the mass of the HFD kidneys was increased, damage to the morphological 
structure of the kidneys was not evident (Figure 12).   
 
Fat Infiltration 
Lipid infiltration analysis using Oil Red O stained tissue sections revealed no fat 
infiltration of either the chow or the HFD rat kidneys, indicating that despite the HFD, 
there was no evidence of renal steatosis (Figure 13).  
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Biomarkers of Function 
Proteinuria 
Both urine protein concentrations and urine creatinine concentrations were 
assessed in order to measure renal function. The urine protein:creatinine ratios of the 
chow and HFD rats did not differ significantly, indicating that the filtering ability of the 
HFD rat kidneys were not damaged (Figure 14). There was also no difference in the urine 
creatinine concentrations of the two groups (Figure 15). 
 
Plasma Cystatin C 
 Although HFD rat plasma cystatin C concentrations appeared higher than chow 
rat plasma cystatin C concentrations, the difference was not sufficient to merit statistical 
significance (Figure 16).  
 
Hydrogen Peroxide 
Urinary hydrogen peroxide:creatinine ratios were found to have no significant 
difference between chow and HFD groups (Figure 17).   
 
Inflammatory Markers 
Renal Tissue TNFα 
Western blot analyses of renal tissue established no significant difference in the 
TNFα protein expression of the chow and HFD rat kidneys (Figure 18). Furthermore, 
ELISA analysis on kidney tissue supernatant revealed no significant difference in the 
TNFα concentrations of the HFD and chow-fed rats (data not shown).  
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Renal Tissue IL-6 
 Quantification of western blots of IL-6 expression in renal tissues showed no 
difference between the chow and HFD animal kidneys (Figure 19).  
 
Oxidative Stress 
Lipid Peroxidation 
 Renal tissue TBARS, a measure of tissue oxidative stress via lipid peroxidation, 
was not significantly elevated in the HFD rats (Figure 20).  
 
Oxidative DNA/RNA Damage 
Plasma levels of oxidized DNA/RNA, quantified as plasma levels of multiple 
oxidative stress markers, including 8-hydroxyguanosine from RNA, 8-OHdG from DNA 
and 8-hydroxyguanine from both DNA and RNA were examined. There were no 
significant differences between the chow and HFD rat groups (Figure 21). 
 
Cumulative Information 
Table 2 lists the means, standard deviations, standard errors of the means, 
normalility testing results, equal variance testing results, and final P-values from all 
statistical analyses. 
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Figure 7 – Body mass of chow and HFD rats. Although the HFD-fed rats tended to 
weigh more than the chow-fed rats, this difference was not statistically significant (n = 
9 chow and n = 8 HFD animals). Data are expressed as means ± SEM. p = 0.056. 
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Figure 8 – Epididymal fat pad mass of chow and HFD rats. Significant differences 
between the fat pad masses of chow and HFD rats demonstrate that adiposity in the 
HFD rats increased considerably (n = 9 chow and n = 8 HFD animals). Data are 
expressed as means ± SEM. *p < 0.001. 
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Figure 9 – Waist circumference of chow and HFD-fed rats. The mean differences 
between the waist circumferences of chow and HFD animals were statistically 
significant, indicating that the HFD induced increases in abdominal obesity (n = 9 
chow and n = 8 HFD animals). Data are expressed as means ± SEM. *p = 0.004. 
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Figure 10 – Tail lengths of chow and HFD animals. There was no difference 
between the tail lengths of the chow and HFD-fed rats, demonstrating that changes in 
waist circumference, epididymal fat pad mass, body mass, and renal mass did not 
result from overall animal growth. (n = 9 chow and n = 8 HFD animals). Data are 
expressed as means ± SEM. p = 0.276. 
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Figure 11 – Renal mass of chow and HFD rats. The HFD-fed rat kidneys were 
significantly heavier than the chow-fed rat kidneys (n = 9 chow and n = 8 HFD 
animals). Data are expressed as means ± SEM. *p = 0.019. 
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Figure 12 – Hematoxylin and eosin staining of kidneys for morphology. 
Hematoxylin and eosin staining shows no signs of morphological damage to the HFD 
kidneys (n = 4 chow and 5 HFD rats). Magnification: (a) 100x; (b) 40x; (c) 200x; (d) 
40x; (e) 100x; (f) 200x; (g) 200x; (h) 200X; (i) 40x; (j) 100x.   
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Figure 13 – Oil Red O staining of kidneys. Oil Red O staining of kidneys from 
HFD-fed rats shows no signs of renal steatosis or fat infiltration (n = 4/group). 
Magnification: (a) 200x; (b) 40x; (c) 100x; (d) 100x; (e) 200x; (f) 40x; (g) 200x; (h) 
100x.  
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Figure 14 – Urine protein:creatinine ratios of chow-fed and HFD-fed rats. There 
was no significant difference between the urine protein:creatinine rations of the two 
diet groups (n = 8/group). Data are expressed as ratio of means ± SEM. p = 0.574. 
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Figure 15 – Urine creatinine in chow-fed and HFD-fed rats. There was no 
significant difference between the urine creatinine concentrations of the two diet 
groups (n = 8/group). Data are expressed as ratio of means ± SEM. p = 0.456. 
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Figure 16 – Plasma cystatin C in chow and HFD rats. Although the average plasma 
cystatin C concentrations in the HFD rat group were higher than that of the chow fed 
rats, this difference was not statistically significant (n = 10/group). Data are expressed 
as means ± SEM. p = 0.233. 
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Figure 17 – Urinary hydrogen peroxide:creatinine in chow and HFD rats. 
Although the HFD rat groups demonstrated higher urinary hydrogen peroxide 
concentrations than the chow fed rats, this difference was not statistically significant 
(n = 10/group). Data are expressed as means ± SEM. p = 0.142.  
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Figure 18 – Renal tissue TNFα  protein expression in chow and HFD rats. There 
was no difference in the TNFα expression of the two diet groups (n = 8/group). A 
positive control (+) was used to demonstrate the accuracy of antibody detection and is 
demonstrated in the first column. The HFD and Chow columns indicate the presence 
of TNFα and show no difference in the darkness of the bands. Data are expressed as 
means ± SEM. p = 0.803.  
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Figure 19 – Renal tissue IL-6 protein expression in chow and HFD rats. There 
was no difference in the IL-6 expression of the two diet groups (n = 5 chow and 6 
HFD rats). A positive control (+) was used to demonstrate the accuracy of antibody 
detection and is demonstrated in the first column. The HFD and C (Chow) columns 
indicate the presence of IL-6 and show no difference in the darkness of the bands. 
Data are expressed as means ± SEM. p = 0.903.  
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Figure 20 – Renal tissue TBARS in chow and HFD rats. There was no significant 
difference in the renal TBARS levels between the chow and HFD-fed rats (n = 
5/group). Data are expressed as means ± SEM. p = 0.600. 
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Figure 21 – Oxidative DNA damage in the plasma of chow and HFD-fed rats. 
Plasma concentrations of chow and HFD-fed rats were statistically equivalent (n = 10 
- 11). Data are expressed as means ± SEM. p = 0.634. 
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Table 2 – Summary of Descriptive Statistics 
Variable Mean±SEM (SD) Normality† Equal 
Variance† 
P-value 
Body Mass (g)     
        Chow (n=9) 349.8±7.98 (23.9) 0.193 (P) 0.841 (P) 0.056 
        HFD (n=8) 376.4±10.3 (29.1)    
Tail Length (cm)     
        Chow (n=9) 20.1±0.30 (0.91) 0.309 (P) 0.712 (P) 0.276 
        HFD (n=8) 20.6±0.32 (0.91)    
Waist Circumference (cm)     
        Chow (n=9) 16.59±0.30 (0.89) 0.492 (P) 0.463 (P) 0.004* 
        HFD (n=8) 17.96±0.27 (0.78)    
Epididymal Fat Pad Mass (g)     
        Chow (n=9) 3.49±0.18 (0.55) 0.693 (P) 0.308 (P) <0.001* 
        HFD (n=8) 5.60±0.38 (1.08)    
Renal Mass (g)     
        Chow (n=9) 1.05±0.04 (0.11) 0.608 (P) 0.898 (P) 0.019* 
        HFD (n=8) 1.19±0.04 (0.11)    
Urine Protein:Creatinine Ratio (AU)     
        Chow (n=8) 6.01±2.86 (8.10) <0.050 NA 0.574‡ 
        HFD (n=8) 3.89±1.31 (3.71)    
Urine Creatinine (mg/L)     
        Chow (n=8) 765.0±110.6 (312.8) 0.697 (P) 0.429 (P) 0.456 
        HFD (n=8) 900.3±137.4 (388.5)    
Urine Hydrogen Peroxide:Creatinine 
Ratio (AU) 
    
        Chow (n=6) 0.014±0.002 (0.006) 0.192 (P) 0.129 (P) 0.142 
        HFD (n=6) 0.026±0.007 (0.018)    
Plasma Cystatin C (ug/mL)     
        Chow (n=10) 14.35±0.99 (3.13) 0.671 (P) 0.990 (P) 0.233 
        HFD (n=10) 16.20±1.12 (3.54)    
TNFα Protein Expression (AU)     
        Chow (n=8) 0.084±0.008 (0.02) 0.368 (P) 0.230 (P) 0.803 
        HFD (n=8) 0.080±0.012 (0.03)    
IL-6 Protein Expression (AU)     
        Chow (n=5) 0.112±0.014 (0.031) 0.747 (P) 0.372 (P) 0.903 
        HFD (n=6) 0.109±0.019 (0.048)    
Renal TBARS (mM/L)     
        Chow (n=5) 26.90±2.02 (4.52) 0.400 (P) 0.138 (P) 0.600 
        HFD (n=5) 28.08±0.80 (1.79)    
Plasma oxidative DNA (pg/mL)     
        Chow (n=10) 887±145 (456) 0.676 (P) 0.176 (P) 0.634 
        HFD (n=11) 1003±188 (626)    
†P = passed 
 
‡Mann-Whitney U 
 
* p ≤ 0.05 
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CHAPTER 5 
DISCUSSION 
Young male Sprague-Dawley rats (1.5 months old) fed a HFD (60% fat) for six 
weeks demonstrated significant increases in waist circumference and epididymal fat pad 
mass along with elevated, though not significant, body mass (Figures 7-9). It is believed 
that had the sample size included additional animals, a statistically significant difference 
in body mass may have been found as well. Epididymal fat pad mass was used to 
determine variations in adiposity between HFD and chow-fed rats because the 
epididymal fat pad can be easily removed from the animal without introducing bias that 
could result from attempting to collect visceral or retroperitoneal fat. Tail length is a 
marker of overall animal growth; there was no difference in the tail lengths of the animals 
on the HFD and chow diets (Figure 10). 
These data also indicate that the rats used for the present study can be classified as 
a model of increased adiposity. The development of an animal model that mimics the 
effects of metabolic syndrome and pre-diabetes was crucial to the interpretation of all 
subsequent results and is consistent with prior studies of HFD intake by both mice and 
rats [3,4,19,31,32,59,65,77,81]. Previous studies completed on HFD and chow fed rats in 
the Sweazea laboratory also demonstrated that these rats had high blood glucose 
concentrations, impaired glucose tolerance, hypertension, endothelial dysfunction, 
oxidative stress and inflammation, indicating that the HFD rats are also a model of 
metabolic syndrome [6,7].  
The mean renal mass of the HFD rats was significantly higher than the chow-fed 
rats (Figure 11). The lack of difference in the tail lengths of the same sample of rats 
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(Figure 10) signifies that the increased mass was not caused by overall growth and 
instead indicates structural damage to the kidneys. Altunaynak et al. (2008) found similar 
results in rats fed a HFD (30% fat) for 12 weeks. These rats became overweight and 
showed increased kidney mass. The damaging effects of hyperglycemia can explain the 
increases in renal mass with a HFD [4]. The proliferation and hypertrophy of mesangial 
cells along with the thickening of the glomerular basement membrane would increase the 
overall mass of the kidney [11,12,39]. Additionally, increased levels of angiotensin II, 
caused by the inappropriate activation of the RAAS, can cause fibrosis, in addition to the 
increased secretion of pro-inflammatory cytokines [18,22,41]. Other explanations include 
vasodilation, inflammation and connective tissue enlargement [4].  
Despite the increases in overall kidney mass, and the hypothesis that the kidneys 
were damaged by the HFD, hematoxylin and eosin staining of the kidneys showed no 
evidence of morphological damage (Figure 12). HFDs with longer feeding protocols have 
been found to cause morphological renal changes such as: glomerular capillary dilation, 
enlarged lumens in the tubules and Bowman’s capsule, amassing of extracellular 
proteins, nephron degradation, glomerular membrane thickening, glomerulosclerosis, 
renal and tubular interstitial cell necrosis, and shortened tubular epitheliums [3,4,18]. 
Therefore, a longer feeding protocol may have allowed for observable renal structural 
damage.  
The accumulation of lipids in renal tissue has been associated with the 
pathogenesis of CKD in animal models [30,37]. There was also no evidence of fat 
infiltration into the kidneys of animals examined in the present study (Figure 13), 
indicating that the kidneys of the HFD rats were able to resist fat infiltration despite 
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increases in visceral adiposity, elevation of plasma TNFα, and hepatic steatosis [6,7]. 
Kume et al. (2007) fed mice a HFD of 45% fat; after developing insulin resistance at 
week four, renal steatosis was evident at week eight, two weeks after the six week 
protocol in this study. Although lipid infiltration caused by HFD feedings are evident in 
the literature, Stemmer et al. (2012) found that despite significant morphological damage 
to the kidneys, 2-month-old male Wistar rats fed a HFD (40% fat) for eleven months did 
not show signs of triglyceride accumulation in the kidney, a finding similar to this study 
[30]. Stemmer et al. (2012) suggest that factors other than lipotoxicity caused by the high 
fat feedings may be involved in renal pathology [30].  
Proteinuria indicates that the filtering ability of the glomerulus is compromised 
and is allowing proteins, which normally remain in the blood, to be passed through the 
filtration membrane and into the urine. In evaluating renal function, the protein albumin 
is sometimes specifically examined; however, by studying total protein excretion, a wider 
picture of filtration ability can be ascertained. Proteinuria, specifically, can be used as a 
marker of endothelial dysfunction as well as a surrogate outcome for renal disease 
progression. Urinary protein concentrations were normalized to urinary creatinine 
concentrations in order to account for variations in urine output [82]. Creatinine is also 
filtered by the kidneys and was therefore evaluated for differences between the HFD and 
chow-fed groups. Ruggiero et al. (2011) found no significant changes in creatinine levels 
after C57BL mice consumed a 45% fat diet for sixteen weeks; the authors felt this 
indicated early stages of renal damage without severe renal functional damage (Figure 
15). In the present study, no statistically significant differences were observed between 
the urinary protein to creatinine ratio for animals ingesting either the chow or HFD 
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(Figure 14), indication that the filtration abilities of the glomeruli were not damaged by 
the HFD or at least not to the extent of allowing large proteins to be excreted. With 
additional feeding time, research suggests that the HFD may have increased blood 
glucose concentrations that would increase stress on the kidneys.  
Plasma cystatin C is considered a marker of early renal dysfunction and the lack 
of difference between the cystatin C concentrations of the HFD and chow-fed rats 
indicates that the six week feeding protocol may not have been long enough to initiate 
functional renal damage (Figure 16). The HFD group did develop higher concentrations 
of plasma cystatin C, however this difference was not statistically significant (p-value = 
0.142). Although cystatin C levels in plasma have been shown to be an early sensitive 
marker of renal dysfunction, these results indicate that the kidneys of the HFD-fed rats 
were not damaged enough so as to prevent cystatin C from being filtered normally by the 
nephrons [54,55,57,83].  
H2O2 is an early marker of oxidative stress and inflammation. Hypertension 
associated with obesity has been shown to increase H2O2 via RAAS activation and 
angiotensin II secretion [60,61]. Despite the increased renal perfusion pressure that is 
associated with hypertension and which elevates H2O2 excretion, there was no significant 
difference in urinary H2O2 between the two groups (Figure 17). Urinary H2O2 was 
initially elevated in the HFD-rats but once H2O2 levels were normalized to creatinine, the 
significance was lost. A true elevation in H2O2 in the HFD group would have indicated 
early renal damage, as H2O2 has been found to be elevated prior to GFR decline, 
proteinuria, and more robust inflammatory and fibrotic responses following high fat 
feedings [59,64,65]. Overall, these results demonstrate that although prior studies indicate 
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that the HFD rats develop plasma and vascular oxidative stress and inflammation in 
addition to endothelial dysfunction, they were not sufficient to impair renal function 
[6,7].  
Both ELISA and Western Blot analyses established no difference between the 
TNFα concentrations of renal tissue (Figure 18). These results corroborate each other and 
confirm that there was no increase in renal TNFα, a marker of inflammation. Although 
increased TNFα expression in adipose tissue has been shown to promote insulin 
resistance in overweight and obese rodent models, there was no indication that the HFD 
caused either fat infiltration into the kidneys or an increase in renal tissue expression of 
this inflammatory cytokine [84,85]. There was also no increase in IL-6 expression, 
another a pro-inflammatory cytokine, which also confirms the lack of observed renal fat 
infiltration (Figure 19). Adipocyte infiltration would likely have resulted in cytokine 
expression. Other experimental models of renal injury indicate that increases in IL-6 
secretion are not necessarily an integral step in progressive renal failure [86]. Overall, the 
lack of significant findings in markers of early renal dysfunction, such as proteinuria and 
urinary H2O2, support the lack of increases in cytokine expression.  
Previous studies completed in the Sweazea laboratory demonstrated that plasma 
TBARS, as a measure of whole body oxidative stress, was increased in the HFD-fed rats. 
Despite the plasma TBARS increases, renal tissue TBARS showed no indication of lipid 
peroxidation or oxidative stress (Figure 20). These results indicate that although the HFD 
rats exhibited generalized oxidative stress, oxidative stress within the kidneys is not yet 
present. Moreover, no significant difference in oxidative DNA/RNA damage between the 
experimental and control groups was observed (Figure 21). Lipid peroxidation levels, 
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examined via TBARS, and DNA/RNA oxidation, have been shown to have a strong 
positive correlation [49,50]. The lack of TNFα and IL-6 expression in renal tissue 
supports the lack of oxidative stress within the kidneys as inflammation and oxidative 
stress have been shown to exacerbate each other [48]. 
In conclusion, aside from morphological data points, the only statistically 
significant finding in this study was an increase in renal mass following a six week HFD. 
It is understood that the study protocol may not have been long enough to cause 
significant renal damage. This study is novel in that it is the first to examine the results of 
a six week HFD; prior to this study, the shortest feeding protocol that is evident in the 
literature is eight weeks. The resilience of the kidneys is made evident by the lack of 
damage after a 60% lard diet. Previous studies conducted in the Sweazea laboratory on 
rats fed a HFD for six weeks have found evidence of significant vascular damage, 
endothelial dysfunction, increased blood glucose concentrations, and liver steatosis [6,7]. 
The infiltration of lipids into the liver but not the kidneys indicates the strength of the 
kidneys. Since the kidneys are designed to filter wastes from the body, the resilience seen 
in this study is understandable. The increasing rates of CKD demonstrate how prolonged 
poorly controlled diabetes must be to cause significant renal damage.  
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